Respimat

Respimat, or commonly referred to as Respimat SMI, with the SMI acronym to mean, Soft Mist Inhaler.

Additional recommended knowledge

Don't let static charges disrupt your weighing accuracy

Recognize and detect the effects of electrostatic charges on your balance

How to quickly check pipettes?

Respimat SMI is an advanced drug delivery device in comparison to MDIs or DPIs used for the treatment of Asthma, COPD, and other respiratory conditions.

Its developer, Boehringer Ingelheim, is currently conducting Phase III clinical trials in the US with a variety of their products, such as Spiriva and Combivent.

Sources

Boehinger-Ingelheim information

Respimat Home